These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 15961275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR, Qi L, Higgins PJ.
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ.
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [Abstract] [Full Text] [Related]

  • 5. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
    Boehm JR, Kutz SM, Sage EH, Staiano-Coico L, Higgins PJ.
    J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, Higgins PJ.
    Exp Cell Res; 2006 Apr 15; 312(7):1093-105. PubMed ID: 16457817
    [Abstract] [Full Text] [Related]

  • 7. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
    Hageman J, Eggen BJ, Rozema T, Damman K, Kampinga HH, Coppes RP.
    Clin Cancer Res; 2005 Aug 15; 11(16):5956-64. PubMed ID: 16115939
    [Abstract] [Full Text] [Related]

  • 8. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ, Sloan-Lancaster J, Berg DT, Richardson MA, Grinnell B, Tseng-Crank J.
    Thromb Haemost; 2001 Dec 15; 86(6):1563-72. PubMed ID: 11776328
    [Abstract] [Full Text] [Related]

  • 9. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 15; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
    Kim DS, Park SH, Park KC.
    Int J Biochem Cell Biol; 2004 Aug 15; 36(8):1482-91. PubMed ID: 15147727
    [Abstract] [Full Text] [Related]

  • 11. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM, Providence KM, Higgins PJ.
    Cell Motil Cytoskeleton; 2001 Mar 15; 48(3):163-74. PubMed ID: 11223948
    [Abstract] [Full Text] [Related]

  • 12. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 15; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 13. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.
    Xu G, Chakraborty C, Lala PK.
    Biochem Biophys Res Commun; 2002 Jun 28; 294(5):1079-86. PubMed ID: 12074587
    [Abstract] [Full Text] [Related]

  • 14. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY, Park J, Yu MR, Kim YS, Ha H, Lee HB.
    Am J Nephrol; 2009 Jun 28; 30(6):481-90. PubMed ID: 19786738
    [Abstract] [Full Text] [Related]

  • 15. Synergy of PEBP2/CBF with mi transcription factor (MITF) for transactivation of mouse mast cell protease 6 gene.
    Ogihara H, Kanno T, Morii E, Kim DK, Lee YM, Sato M, Kim WY, Nomura S, Ito Y, Kitamura Y.
    Oncogene; 1999 Aug 12; 18(32):4632-9. PubMed ID: 10467408
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
    Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA.
    Arterioscler Thromb Vasc Biol; 2006 Apr 12; 26(4):737-43. PubMed ID: 16373605
    [Abstract] [Full Text] [Related]

  • 17. Isoforms of mi transcription factor preferentially expressed in cultured mast cells of mice.
    Oboki K, Morii E, Kataoka TR, Jippo T, Kitamura Y.
    Biochem Biophys Res Commun; 2002 Feb 01; 290(4):1250-4. PubMed ID: 11811997
    [Abstract] [Full Text] [Related]

  • 18. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N.
    J Mol Cell Cardiol; 2009 Apr 01; 46(4):545-52. PubMed ID: 19168071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.